Editing GSK plc (section)

===Consumer healthcare===
GSK's consumer healthcare division, which earned £5.2{{nbsp}}billion in 2013, sells oral healthcare, including [[List of toothpaste brands|Aquafresh]], [[List of toothpaste brands|Macleans]] and [[Sensodyne]] toothpastes. GSK also previously owned the [[Lucozade]] and [[Ribena]] brands of soft drinks, but they were sold in 2013, to [[Suntory]] for £1.35bn.<ref name=Monaghan/> Other products include [[Docosanol|Abreva]] to treat cold sores; Night Nurse, a cold remedy; Breathe Right [[nasal strip]]s; and [[Nicoderm]] and [[Nicorette]] nicotine replacements.<ref name="Maj07">{{cite book |url=https://books.google.com/books?id=vI9vE7_LJX4C&pg=PT242 |title=Product management in India |publisher=PHI Learning |year=2007 |page=242 |isbn=978-81-203-3383-3 |first=Ramanuj |last=Majumdar |edition=3rd}}</ref> In March 2014, it recalled [[Orlistat|Alli]], an over-the-counter weight-loss drug, in the United States and [[Puerto Rico]] because of possible tampering, following customer complaints.<ref>{{Cite web |last=Smith |first=Aaron |date=27 March 2014 |title=Alli, a popular weight-loss drug, is recalled by maker GlaxoSmithKline for possible tampering |url=https://money.cnn.com/2014/03/27/news/companies/glaxosmithkline-alli-recall/index.html |url-status=live |archive-url=https://web.archive.org/web/20140328051325/http://money.cnn.com/2014/03/27/news/companies/glaxosmithkline-alli-recall/ |archive-date=28 March 2014 |access-date=11 September 2023 |website=CNNMoney}}</ref> On 18 July 2022, GSK formally spun off its consumer healthcare business as a separate entity, [[Haleon]].<ref>{{cite web |last1=Kansteiner |first1=Fraiser |title=GSK offloads remaining stake in Haleon for £1.25B |url=https://www.fiercepharma.com/pharma/gsk-plans-offload-remaining-stake-consumer-health-spinoff-haleon-through-385m-share-offer#:~:text=GSK%20completed%20the%20spinoff%20of,%2C%20Sensodyne%2C%20Tums%20and%20Theraflu. |website=www.fiercepharma.com |language=en |date=17 May 2024}}</ref><ref>{{cite web |title=Consumer Healthcare Demerger {{!}} GSK |url=https://www.gsk.com/en-gb/investors/corporate-actions/consumer-healthcare-demerger/ |website=www.gsk.com}}</ref><ref>{{cite web |last1=Roland |first1=Denise |title=GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon |url=https://www.wsj.com/articles/gsk-spins-off-36-billion-consumer-healthcare-business-haleon-11658135866 |website=The Wall Street Journal |date=18 July 2022 |language=en}}</ref>